seriously ......................."Apart from $47 million in cash and an additional $75-million non-dilutive credit facility, Mesoblast will likely need additional capital to finance its late-stage development, the analyst said."
I think we have moved on from this issue.
- Forums
- ASX - By Stock
- MSB
- Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish
MSB
mesoblast limited
Add to My Watchlist
6.37%
!
$2.35
Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish, page-3
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
